Psychiatry and Psychology [F] » Mental Disorders [F03] » Mood Disorders » Depressive Disorder » Depressive Disorder, Treatment-Resistant
Description
Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.) MeSH
Hierarchy View
Phase 4 Indicated Drugs (20)
Phase 3 Indicated Drugs (13)
Other Experimental Indicated Drugs (14)
Organization Involved with Phase 4 Indications (28)
Organization Involved with Phase 3 Indications (15)
Organization Involved with Phase 2 Indications (68)
American British Cowdray Medical Center
Atlanta Institute of Medicine and Research
Clinical Neuroscience Solutions, Inc.
Fundação de Amparo à Pesquisa do Estado de São Paulo
German Federal Ministry of Education and Research
National Institutes of Health (NIH)
North Star Medical Research LLC
Northwest Clinical Research Center
Oregon Center for Clinical Investigations, Inc
Patient Priority Clinical Sites, LLC
Reckitt Benckiser Pharmaceutical
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
